Ethiopia Business News API

{
    "totalArticles": 12684,
    "articles": [
        {
            "id": "8774a361f3e695a9fa7ce0a41327b196",
            "title": "hepatic delivery data at RNA Leaders Europe Conference",
            "description": "/PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (\"Ribo\" or \"the Company\", Hong Kong Stock Exchange code: 6938) has been invited to give a speech at the RNA...",
            "content": "SUZHOU, China and MÖLNDALS, Sweden, March 16, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (\"Ribo\" or \"the Company\", Hong Kong Stock Exchange code: 6938) has been invited to give a speech at the RNA Leaders Europe Conference in Vienna, Aus... [1088 chars]",
            "url": "https://www.prnewswire.com/news-releases/ribo-to-present-ex-hepatic-delivery-data-at-rna-leaders-europe-conference-302715369.html",
            "image": "https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?p=facebook",
            "publishedAt": "2026-03-17T03:00:00Z",
            "lang": "en",
            "source": {
                "id": "4e4307a07d2ce1e31acaf932954d3dd9",
                "name": "PR Newswire",
                "url": "https://www.prnewswire.com"
            }
        },
        {
            "id": "15362495fc8ca8044daef46b55e70fe2",
            "title": "Ant Group unit clears regulatory step for Bright Smart takeover",
            "description": "Shares of Bright Smart Securities surged 58% after an Ant Group unit completed the required steps to acquire Hong Kong listed brokerage Bright Smart Securities.",
            "content": "Shares of Bright Smart Securities surged as much as 82% on Tuesday after an Ant Group unit completed the required steps to acquire the Hong Kong-listed brokerage.\nThe stock later pared gains to trade 70% higher as of 10.45p.m. ET, the highest since J... [1208 chars]",
            "url": "https://www.cnbc.com/2026/03/17/ant-group-bright-smart-securities-acquisition-hong-kong-brokerage.html",
            "image": "https://image.cnbcfm.com/api/v1/image/108120073-1742788724612-gettyimages-2205941228-Ant_Group_Buildings_in_Chongqing.jpeg?v=1742799223&w=1920&h=1080",
            "publishedAt": "2026-03-17T02:59:00Z",
            "lang": "en",
            "source": {
                "id": "32c2ad3fb41cb87b5b847d750028dff0",
                "name": "CNBC",
                "url": "https://www.cnbc.com"
            }
        },
        {
            "id": "b649cc71c07c4f965b1237416d2766d6",
            "title": "Investigational oral therapy shows safety and potential benefits in ALS trial",
            "description": "In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement and potential clinical benefits.",
            "content": "In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement and potential clinic... [2812 chars]",
            "url": "https://www.news-medical.net/news/20260316/Investigational-oral-therapy-shows-safety-and-potential-benefits-in-ALS-trial.aspx",
            "image": "https://www.news-medical.net/image-handler/picture/2014/7/Neuroscience-620x480.jpg",
            "publishedAt": "2026-03-17T02:30:00Z",
            "lang": "en",
            "source": {
                "id": "f2ca7a45d20357cb42858868cb4a4946",
                "name": "News-Medical",
                "url": "https://www.news-medical.net"
            }
        }
    ]
}